Careful management of patient expectations is key to achieving optimal outcomes.
Ophthalmology Times: May/June 2025
Ixo-vec shows sustained efficacy and reduces injection burden through 4 years in clinical trials
tPA: A (new) tool in the uveitis armamentarium for patient care
Published: | Updated:
Intracameral tPA can treat fibrinous clots in severe anterior uveitis.
Changing demographics and increasing trial complexity present challenges and opportunities.
Timely diagnosis and personalized treatment are key to improving visual outcomes.
Deep learning discerns IIH, NAION, and normal eyes using single fundus image.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
4
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
5